RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
4.940
-0.300 (-5.73%)
At close: Jun 2, 2026, 4:00 PM EDT
5.05
+0.11 (2.23%)
After-hours: Jun 2, 2026, 5:44 PM EDT
RxSight Market Cap
RxSight has a market cap or net worth of $204.5 million as of June 2, 2026. Its market cap has decreased by -64.54% in one year.
Market Cap
204.50M
Enterprise Value
-2.55M
1-Year Change
-64.54%
Ranking
Category
Stock Price
$4.94
Market Cap Chart
Since the IPO on July 30, 2021, RxSight's market cap has decreased from $424.33M to $204.50M, a decrease of -51.81%. That is a compound annual growth rate of -13.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 204.50M | -52.27% |
| Dec 31, 2025 | 428.44M | -69.08% |
| Dec 31, 2024 | 1.39B | -4.17% |
| Dec 29, 2023 | 1.45B | 311.68% |
| Dec 30, 2022 | 351.23M | 14.14% |
| Dec 31, 2021 | 307.73M | -27.48% |
| Jul 30, 2021 | 424.33M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Electromed | 312.32M |
| Sight Sciences | 264.43M |
| Quantum-Si incorporated | 259.13M |
| Profound Medical | 251.21M |
| Treace Medical Concepts | 224.46M |
| TriSalus Life Sciences | 209.43M |
| Lucid Diagnostics | 196.49M |
| InfuSystem Holdings | 183.05M |